Physician profile
Daniela Molena
NPI 1336152487
$220,772.78
in general payments reported to CMS, 2019-2025
14 companies · $74K in 2025
The $74K reported for 2025 was more than what 98% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $22K · 2021: $26K · 2022: $25K · 2023: $57K · 2024: $18K · 2025: $74K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $102K · Travel and Lodging: $29K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $4,726 · Grant: $2,020.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $102,457.27 |
| Travel and Lodging | $28,980.60 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,113.62 |
| Food and Beverage | $4,726.00 |
| Grant | $2,019.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Uk Limited | $104,949.67 | 2022-2025 | Imfinzi, Tagrisso |
| Medical Device Business Services, INC. | $29,872.65 | 2020-2024 | Echelon Flex, Echelon Endopath |
| Ethicon INC. | $22,046.63 | 2020-2025 | Dermabond, Echelon Flex, Surgicel Nu-Knit |
| Astrazeneca Pharmaceuticals Lp | $14,503.48 | 2022-2025 | Imfinzi, Tagrisso |
| Ethicon US, LLC | $10,461.96 | 2021-2024 | Dermabond, Surgicel Nu-Knit, Prolene |
| Intuitive Surgical, INC. | $9,733.88 | 2021-2025 | |
| Janssen Research & Development, LLC | $9,071.01 | 2025 | |
| Merck Sharp & Dohme LLC | $5,960.00 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $5,089.75 | 2021 | |
| Medtronic, INC. | $4,452.66 | 2021-2025 | Signia, Penditure, Valiant Captivia |
| Boston Scientific Corporation | $4,321.02 | 2020-2023 | |
| Ambu INC. | $125.00 | 2023 | |
| Pinnacle Biologics, INC | $115.57 | 2019 | |
| Covidien Lp | $69.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniela Molena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.